BACKGROUND: This report describes the use of microdialysis in conjunction with deep brain stimulation (DBS) surgery to assess extracellular levels of neurotransmitters within the human basal ganglia (BG). Electrical stimulation of the subthalamic nucleus (STN) is an efficacious treatment for advanced Parkinson's disease, yet the mechanisms of STN DBS remain poorly understood. Measurement of neurotransmitter levels within the BG may provide insight into mechanisms of DBS, but such an approach presents technical challenges. METHODS: After microelectrode recordings confirmed location of STN, a custom microdialysis guide cannula was inserted. A CMA (Stockholm, Sweden) microdialysis probe was then positioned to the same depth as the microrecording electrode in STN or 2mm inferiorly to record in the substantia nigra. The catheter was perfused at a rate of 2.0 microL/min with a sterile mock CSF solution and samples of extracellular fluid were collected at regular intervals. Dialysate samples were analyzed using high-pressure liquid chromatography (HPLC) detection procedures for quantitation of glutamate, gamma-aminobutyric acid (GABA), and dopamine. RESULTS: Levels of neurotransmitters were reliably identified in dialysate samples using HPLC. By monitoring concentrations of glutamate, GABA and dopamine, we were able to demonstrate what seemed to be a steady state baseline within approximately 30 min. CONCLUSION: Microdialysis during DBS surgery is a feasible method for assessing levels of glutamate, GABA and dopamine within the human BG. Obtaining a steady state baseline of neurotransmitter levels appears feasible, thus making future studies of intraoperative microdialysis during DBS meaningful. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND: This report describes the use of microdialysis in conjunction with deep brain stimulation (DBS) surgery to assess extracellular levels of neurotransmitters within the human basal ganglia (BG). Electrical stimulation of the subthalamic nucleus (STN) is an efficacious treatment for advanced Parkinson's disease, yet the mechanisms of STN DBS remain poorly understood. Measurement of neurotransmitter levels within the BG may provide insight into mechanisms of DBS, but such an approach presents technical challenges. METHODS: After microelectrode recordings confirmed location of STN, a custom microdialysis guide cannula was inserted. A CMA (Stockholm, Sweden) microdialysis probe was then positioned to the same depth as the microrecording electrode in STN or 2mm inferiorly to record in the substantia nigra. The catheter was perfused at a rate of 2.0 microL/min with a sterile mock CSF solution and samples of extracellular fluid were collected at regular intervals. Dialysate samples were analyzed using high-pressure liquid chromatography (HPLC) detection procedures for quantitation of glutamate, gamma-aminobutyric acid (GABA), and dopamine. RESULTS: Levels of neurotransmitters were reliably identified in dialysate samples using HPLC. By monitoring concentrations of glutamate, GABA and dopamine, we were able to demonstrate what seemed to be a steady state baseline within approximately 30 min. CONCLUSION: Microdialysis during DBS surgery is a feasible method for assessing levels of glutamate, GABA and dopamine within the human BG. Obtaining a steady state baseline of neurotransmitter levels appears feasible, thus making future studies of intraoperative microdialysis during DBS meaningful. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Elin Diczfalusy; Peter Zsigmond; Nil Dizdar; Anita Kullman; Dan Loyd; Karin Wårdell Journal: Med Biol Eng Comput Date: 2011-11-13 Impact factor: 2.602
Authors: Frances Xin; Erin Fischer; Christopher Krapp; Elizabeth N Krizman; Yemin Lan; Clementina Mesaros; Nathaniel W Snyder; Amita Bansal; Michael B Robinson; Rebecca A Simmons; Marisa S Bartolomei Journal: Horm Behav Date: 2018-05-18 Impact factor: 3.587
Authors: Tina Suominen; Päivi Uutela; Raimo A Ketola; Jonas Bergquist; Lars Hillered; Moshe Finel; Hongbo Zhang; Aki Laakso; Risto Kostiainen Journal: PLoS One Date: 2013-06-27 Impact factor: 3.240
Authors: A Stefani; E Fedele; J Vitek; M Pierantozzi; S Galati; F Marzetti; A Peppe; M S Bassi; G Bernardi; P Stanzione Journal: Cell Death Dis Date: 2011-05-05 Impact factor: 8.469
Authors: Juan M Rojas Cabrera; J Blair Price; Aaron E Rusheen; Abhinav Goyal; Danielle Jondal; Abhijeet S Barath; Hojin Shin; Su-Youne Chang; Kevin E Bennet; Charles D Blaha; Kendall H Lee; Yoonbae Oh Journal: Rev Anal Chem Date: 2020-12-31 Impact factor: 3.067